Company number 09613290
Status Active
Incorporation Date 29 May 2015
Company Type Private Limited Company
Address ABACUS HOUSE THE ROPEWALK, GARSTANG, PRESTON, LANCASHIRE, UNITED KINGDOM, PR3 1NS
Home Country United Kingdom
Nature of Business 71200 - Technical testing and analysis
Phone, email, etc
Since the company registration seven events have happened. The last three records are Total exemption small company accounts made up to 31 March 2016; Director's details changed for Mr Nicholas Michael Lyon on 26 July 2016; Annual return made up to 31 May 2016 with full list of shareholders
Statement of capital on 2016-06-15
GBP 100
. The most likely internet sites of LYON PHARMA CONSULTING LTD are www.lyonpharmaconsulting.co.uk, and www.lyon-pharma-consulting.co.uk. The predicted number of employees is 1 to 10. The company’s age is ten years and six months. Lyon Pharma Consulting Ltd is a Private Limited Company.
The company registration number is 09613290. Lyon Pharma Consulting Ltd has been working since 29 May 2015.
The present status of the company is Active. The registered address of Lyon Pharma Consulting Ltd is Abacus House The Ropewalk Garstang Preston Lancashire United Kingdom Pr3 1ns. . LYON, Nicholas Michael is a Director of the company. The company operates in "Technical testing and analysis".
Current Directors
LYON PHARMA CONSULTING LTD Events
22 Dec 2016
Total exemption small company accounts made up to 31 March 2016
26 Jul 2016
Director's details changed for Mr Nicholas Michael Lyon on 26 July 2016
15 Jun 2016
Annual return made up to 31 May 2016 with full list of shareholders
Statement of capital on 2016-06-15
14 Sep 2015
Director's details changed for Mr Nicholas Michael Lyon on 14 September 2015
04 Jun 2015
Current accounting period shortened from 31 May 2016 to 31 March 2016
04 Jun 2015
Registered office address changed from 648 Garstang Road Barton Preston Lancashire PR3 5DR England to Abacus House the Ropewalk Garstang Preston Lancashire PR3 1NS on 4 June 2015
29 May 2015
Incorporation
Statement of capital on 2015-05-29
-
MODEL ARTICLES ‐
Model articles adopted (Amended Provisions)